Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
Journey Medical Corporation將於2024年5月13日公佈2024年第一季度財務業績
Download as PDF May 07, 2024
以 PDF 格式下載 2024年5月7日
Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30 p.m. ET
公司將於美國東部時間2024年5月13日下午 4:30 舉辦電話會議，討論財務業績並提供公司最新情況
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or the "Company") (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its first quarter 2024 financial results after the U.S. financial markets close on Monday, May 13, 2024. Journey Medical management will conduct a conference call and audio webcast on Monday, May 13, 2024 at 4:30 p.m. ET.
亞利桑那州斯科茨代爾，2024年5月7日（GLOBE NEWSWIRE）——專注於銷售和營銷經美國食品藥品管理局批准的用於治療皮膚病的處方藥產品的商業階段製藥公司Journey Medical（“Journey Medical” 或 “公司”）（納斯達克股票代碼：DERM）今天宣佈，該公司將在2024年5月13日星期一美國金融市場收盤後發佈其2024年第一季度財務業績。Journey Medical管理層將於美國東部時間2024年5月13日星期一下午4點30分進行電話會議和網絡音頻直播。
To listen to the conference call, interested parties within the U.S. should dial 1-866-777-2509 (domestic) or 1-412-317-5413 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to join the Journey Medical conference call. Participants can register for the conference by navigating to https://dpregister.com/sreg/10188768/fc6df642e0. Please note that registered participants will receive their dial-in number upon registration.
要收聽電話會議，美國境內的有關各方應撥打1-866-777-2509（國內）或1-412-317-5413（國際）。所有來電者應在預定開始時間前大約 10 分鐘撥入，並要求參加 Journey Medical 電話會議。參與者可以通過導航到以下地址註冊會議 https://dpregister.com/sreg/10188768/fc6df642e0。請注意，註冊的參與者將在註冊時收到他們的撥入號碼。
A live audio webcast can be accessed on the News and Events page of the Investors section of Journey Medical's website, www.journeymedicalcorp.com, and will remain available for replay for approximately 30 days after the conference call.
可以在Journey Medical網站 “投資者” 部分的新聞和活動頁面上訪問網絡直播， www.journeymedicalcorp.com，並且將在電話會議結束後的大約 30 天內繼續可供重播。
About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical") is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The company currently markets seven branded and two generic products that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology's most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical's common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission ("SEC"). For additional information about Journey Medical, visit www.journeymedicalcorp.com.
關於卓越醫療公司
Journey Medical Corporation（納斯達克股票代碼：DERM）（“Journey Medical”）是一家商業階段的製藥公司，主要通過其高效的銷售和營銷模式，銷售和營銷經美國食品藥品管理局批准的用於治療皮膚病的處方藥產品。該公司目前銷售七種品牌和兩種仿製產品，這些產品有助於治療和治癒常見的皮膚病。Journey Medical團隊由行業專家組成，他們在開發和商業化皮膚科一些最成功的處方品牌方面擁有豐富的經驗。Journey Medical位於亞利桑那州斯科茨代爾，由豐澤生物技術公司（納斯達克股票代碼：FBIO）創立。Journey Medical的普通股根據經修訂的1934年證券交易法註冊，並定期向美國證券交易委員會（“SEC”）提交報告。有關 Journey Medical 的更多信息，請訪問 www.journeymedicalcorp.com。
Company Contact:
Jaclyn Jaffe
Journey Medical Corporation
(781) 652-4500
ir@jmcderm.com
公司聯繫人：
Jaclyn Jaffe
卓越醫療公司
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
媒體關係聯繫人：
託尼·普洛霍羅斯
6 度
(908) 591-2839
tplohoros@6degreespr.com
Source: Journey Medical Corporation
資料來源：旅程醫療公司
Released May 7, 2024
2024 年 5 月 7 日發佈
譯文內容由第三人軟體翻譯。